Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines

Xin Liu, Xiu-Jie Wang
doi: https://doi.org/10.1101/2020.01.29.924100
Xin Liu
1Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu-Jie Wang
1Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
2University of Chinese Academy of Sciences, Beijing, China
3Innovation Academy for Seed Design, Chinese Academy of Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xjwang@genetics.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: January 2020 to May 2022

AbstractFullPdf
Jan 202045181071658
Feb 2020714316085928
Mar 2020506711863240
Apr 202019984062384
May 2020873148888
Jun 202049987372
Jul 202036492240
Aug 202033427149
Sep 2020256107223
Oct 20202113595
Nov 20201603655
Dec 20201714259
Jan 20212452758
Feb 20212331942
Mar 202114733110
Apr 20211461756
May 20211201955
Jun 20211161551
Jul 2021196737
Aug 20211241037
Sep 2021258734
Oct 2021179645
Nov 20211101040
Dec 20211181116
Jan 20221463023
Feb 20221503115
Mar 20222423213
Apr 20223173224
May 2022601810
Back to top
PreviousNext
Posted January 29, 2020.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu, Xiu-Jie Wang
bioRxiv 2020.01.29.924100; doi: https://doi.org/10.1101/2020.01.29.924100
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu, Xiu-Jie Wang
bioRxiv 2020.01.29.924100; doi: https://doi.org/10.1101/2020.01.29.924100

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Bioinformatics
Subject Areas
All Articles
  • Animal Behavior and Cognition (3482)
  • Biochemistry (7329)
  • Bioengineering (5301)
  • Bioinformatics (20212)
  • Biophysics (9985)
  • Cancer Biology (7706)
  • Cell Biology (11273)
  • Clinical Trials (138)
  • Developmental Biology (6425)
  • Ecology (9923)
  • Epidemiology (2065)
  • Evolutionary Biology (13292)
  • Genetics (9353)
  • Genomics (12559)
  • Immunology (7681)
  • Microbiology (18964)
  • Molecular Biology (7421)
  • Neuroscience (40915)
  • Paleontology (298)
  • Pathology (1226)
  • Pharmacology and Toxicology (2130)
  • Physiology (3145)
  • Plant Biology (6842)
  • Scientific Communication and Education (1271)
  • Synthetic Biology (1893)
  • Systems Biology (5299)
  • Zoology (1086)